PharmaCyte’s Competitors, Revenue, Number of Employees, Funding, Acquisitions & News

PharmaCyte Biotech is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes. Read more

Kenneth L. Waggoner's photo - Chairman & CEO of PharmaCyte

Chairman & CEO

Kenneth L. Waggoner

CEO Approval Rating

87/100

Founded:

1996

Status:

PublicOtherPMCB

TOP COMPETITORS OR ALTERNATIVES

RANK

COMPANY

CEO

CEO RATING

EMPLOYEES

FUNDING

REVENUE

Missing a competitor? Contribute!

Olema Oncology is one of PharmaCyte's top competitors. Olema Oncology was founded in 2007, and its headquarters is in San Francisco, California. Like PharmaCyte, Olema Oncology also works within the Pharmaceuticals sector. Olema Oncology has 8 more employees than PharmaCyte.

Puma Biotechnology is PharmaCyte's #2 rival. Puma Biotechnology was founded in 2010 in Los Angeles, California. Puma Biotechnology operates in the Pharmaceuticals industry. Puma Biotechnology generates $179.4M more revenue than PharmaCyte.

OncBioMune is a top competitor of PharmaCyte. OncBioMune is a Public company that was founded in Baton Rouge, Louisiana in 2005. OncBioMune is in the Pharmaceuticals field. OncBioMune has 2 fewer employees vs. PharmaCyte.

Weigh-in!

Help the Owler community know more

Competitor - 1/1

Is Juno a competitor of PharmaCyte?

Quarterly and Annual Revenue

Coming soon for PharmaCyte!

Annual Revenue

$ < 1M

PharmaCyte's revenue is the ranked 13th among it's top 10 competitors. The top 10 competitors average 2.7B.

Acquisitions

No recent acquisitions found related to PharmaCyte

PharmaCyte Funding History

$1M

Since PharmaCyte was founded in 1996, it has participated in 1 round of funding. In total PharmaCyte has raised $1.0M. PharmaCyte's funding round was on Jan 2016 for a total of $1.0M

ROUND

FUNDING DATE

AMOUNT

INVESTORS

Unattributed
Jan 2016
$1M
-

Total Funding: $1M

Since PharmaCyte was founded in 1996, it has participated in 1 round of funding. In total PharmaCyte has raised $1.0M. PharmaCyte's funding round was on Jan 2016 for a total of $1.0M

Investments

No recent investments found related to PharmaCyte

PharmaCyte News

July 27, 2020BioSpace

PharmaCyte Biotech Announces Submission of Drug Master File to FDA for Company's Pancreatic Cancer Therapy

PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnology company focused on developing cellular therap... See more »
July 13, 2020Drug Genius

PharmaCyte Biotech Successfully Completes Container Closure Integrity Test

LAGUNA HILLS, Calif.-(BUSINESS WIRE)-#INDstatus-PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnolo... See more »
June 23, 2020MarketScreener

PharmaCyte Biotech Provides IND Submission Update for Pancreatic Cancer Clinical Trial

(marketscreener.com) PharmaCyte Biotech, Inc. , a biotechnology company focused on developing cellula... See more »
June 10, 2020Picante Today

PharmaCyte Biotech Successfully Develops "Change History" for its Clinical Trial Product for Pancreatic Cancer

LAGUNA HILLS, Calif.-(BUSINESS WIRE)-#INDstatus-PharmaCyte Biotech, Inc. (OTCQB: PMCB), a biotechnolo... See more »

PharmaCyte Press Releases

January 27, 2020GlobalNewswire

PharmaCyte Biotech's Pancreatic Cancer Therapy Passes Critical FDA-Required Tests as Countdown to IND Submission Begins

NEW YORK, NY, Jan. 27, 2020 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) announced that its c... See more »
January 14, 2020GlobalNewswire

PharmaCyte Biotech Addressing Unmet Need in Patients with LAPC as Pancreatic Cancer 5-Year Survival Rate Increases to 10%

NEW YORK, NY, Jan. 14, 2020 (GLOBE NEWSWIRE) -- This month the American Cancer Society announced that... See more »
December 11, 2019GlobalNewswire

PharmaCyte Biotech Finalizes Pancreatic Cancer Treatment for U.S. FDA Approval to Begin Clinical Trial

NEW YORK, NY, Dec. 11, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has a clinical trial... See more »
November 12, 2019GlobalNewswire

PharmaCyte Biotech's "Release Testing" Last Critical Event Before Submission of Investigational New Drug Application

NEW YORK, NY, Nov. 12, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has reduced a long l... See more »
October 28, 2019GlobalNewswire

PharmaCyte Biotech to Change Future of Treating Diseases with Validation of Encapsulation Technology in Pancreatic Cancer Trial

NEW YORK, NY, Oct. 28, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) has a technology tha... See more »
September 23, 2019GlobeNewswire

PharmaCyte Biotech's Pancreatic Cancer Therapy Production in Final Days of Key Manufacturing Run

NEW YORK, NY, Sept. 23, 2019 (GLOBE NEWSWIRE) -- PharmaCyte Biotech (OTCQB: PMCB) and its partner, Au... See more »
February 4, 2019GlobeNewswire

PharmaCyte Biotech Nearing Major Milestone-An Open IND with the FDA

NEW YORK, NY, Feb. 04, 2019 (GLOBE NEWSWIRE) -- Clinical stage biotechnology company PharmaCyte Biote... See more »

PharmaCyte Videos

Social Statistics

Headquarters

23046 Avenida de la Carlota Suite 600

Laguna Hills, California92653

1-917-595-2850

Driving Directions »

Trending Companies

Summary

ABOUT

Overview

PharmaCyte Biotech is a clinical-stage biotechnology company focused on developing and preparing to commercialize treatments for cancer and diabetes. PharmaCyte was founded in 1996. PharmaCyte's headquarters is located in Laguna Hills, California, USA...

CEO

PharmaCyte's Chairman & CEO, Kenneth L. Waggoner, currently has an approval rating of 87%. PharmaCyte's primary competitors are Olema Oncology, Puma Biotechnology & OncBioMune.

Website

pharmacyte.com

Frequently Asked Questions about PharmaCyte

  1. When was PharmaCyte founded?

    PharmaCyte was founded in 1996
  2. Who is PharmaCyte's CEO?

    PharmaCyte's CEO is Kenneth L. Waggoner
  3. How much revenue does PharmaCyte generate?

    PharmaCyte generates $ < 1M in revenue
  4. How much funding does PharmaCyte have?

    PharmaCyte has historically raised $1M in funding
  1. Where is PharmaCyte's headquarters?

    PharmaCyte's headquarters is in Laguna Hills California, USA
  2. How many employees does PharmaCyte have?

    PharmaCyte has 4 employees
  3. What sector does PharmaCyte operate in?

    PharmaCyte is in Pharmaceuticals
  4. Who are PharmaCyte's competitors?

    PharmaCyte's top competitors are Olema Oncology, Puma Biotechnology, OncBioMune